159
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Retrospective Evaluation of Non-Invasive Assessment Based on Routine Laboratory Markers for Assessing Advanced Liver Fibrosis in Chronic Hepatitis B Patients

, , , , , , , , , & show all
Pages 5159-5171 | Published online: 25 May 2022

References

  • Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect. 2011;17(2):107–115. doi:10.1111/j.1469-0691.2010.03432.x
  • European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatitis C virus infection. J Hepatol. 2011;55(2):245–264. doi:10.1016/j.jhep.2011.02.023
  • Williams R. Global challenges in liver disease. Hepatology. 2006;44(3):521–526. doi:10.1002/hep.21347
  • Serraino R, Mazzitelli M, Greco G, et al. Risk factors for hepatitis B and C among healthy population: a community-based survey from four districts of Southern Italy. Infez Med. 2020;28(2):223–226.
  • Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115(2):209–218. doi:10.1172/JCI24282
  • Grant A, Neuberger J. Guidelines on the use of liver biopsy in clinical practice. British Society of Gastroenterology. Gut. 1999;45(Suppl 4):IV1–IV11. doi:10.1136/gut.45.2008.iv1
  • Pinzani M, Vizzutti F, Arena U, Marra F. Technology insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography. Nat Clin Pract Gastroenterol Hepatol. 2008;5(2):95–106. doi:10.1038/ncpgasthep1025
  • Martinez SM, Crespo G, Navasa M, Forns X. Noninvasive assessment of liver fibrosis. Hepatology. 2011;53(1):325–335. doi:10.1002/hep.24013
  • Gorka-Dynysiewicz J, Pazgan-Simon M, Zuwala-Jagiello J. Pentraxin 3 detects clinically significant fibrosis in patients with chronic viral hepatitis C. Biomed Res Int. 2019;2019:2639248. doi:10.1155/2019/2639248
  • European Association for Study of Liver, Asociacion Latinoamericana para el Estudio del H. EASL-ALEH clinical practice guidelines: non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63(1):237–264.
  • Shiha G, Ibrahim A, Helmy A, et al. Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update. Hepatol Int. 2017;11(1):1–30. doi:10.1007/s12072-016-9760-3
  • Sporea I, Bota S, Peck-Radosavljevic M, et al. Acoustic radiation force impulse elastography for fibrosis evaluation in patients with chronic hepatitis C: an international multicenter study. Eur J Radiol. 2012;81(12):4112–4118. doi:10.1016/j.ejrad.2012.08.018
  • Tachi Y, Hirai T, Kojima Y, et al. Liver stiffness measurement using acoustic radiation force impulse elastography in hepatitis C virus-infected patients with a sustained virological response. Aliment Pharmacol Ther. 2016;44(4):346–355. doi:10.1111/apt.13695
  • Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560–1599. doi:10.1002/hep.29800
  • Peng X, Tian A, Li J, et al. Diagnostic value of FibroTouch and non-invasive fibrosis indexes in hepatic fibrosis with different aetiologies. Dig Dis Sci. 2021. doi:10.1007/s10620-021-07049-4
  • Guo L, Zheng L, Hu L, Zhou H, Yu L, Liang W. Transient elastography (FibroScan) performs better than non-invasive markers in assessing liver fibrosis and cirrhosis in autoimmune hepatitis patients. Med Sci Monit. 2017;23:5106–5112. doi:10.12659/MSM.907300
  • Bai DS, Zhou BH, Qian JJ, Zhang C, Jin SJ, Jiang GQ. Effects of laparoscopic splenectomy and azygoportal disconnection on liver synthesis function and cirrhosis: a 2-year prospective study. Surg Endosc. 2020;34(11):5074–5082. doi:10.1007/s00464-019-07307-7
  • Kang NL, Zhang JM, Lin MX, et al. Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients. World J Gastroenterol. 2020;26(27):3952–3962. doi:10.3748/wjg.v26.i27.3952
  • Cao X, Shang QH, Chi XL, et al. Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virus. World J Gastroenterol. 2020;26(10):1067–1079. doi:10.3748/wjg.v26.i10.1067
  • Sandrin L, Tanter M, Gennisson JL, Catheline S, Fink M. Shear elasticity probe for soft tissues with 1-D transient elastography. IEEE Trans Ultrason Ferroelectr Freq Control. 2002;49(4):436–446. doi:10.1109/58.996561
  • Boursier J, Zarski JP, de Ledinghen V, et al. Determination of reliability criteria for liver stiffness evaluation by transient elastography. Hepatology. 2013;57(3):1182–1191. doi:10.1002/hep.25993
  • Bedossa P; The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology. 1994;20(1):15–20. doi:10.1002/hep.1840200104
  • Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol. 1991;13(3):372–374. doi:10.1016/0168-8278(91)90084-O
  • Zhuang Y, Ding H, Zhang Y, Sun H, Xu C, Wang W. Two-dimensional shear-wave elastography performance in the noninvasive evaluation of liver fibrosis in patients with chronic hepatitis B: comparison with serum fibrosis indexes. Radiology. 2017;283(3):873–882. doi:10.1148/radiol.2016160131
  • Wong GL, Espinosa WZ, Wong VW. Personalized management of cirrhosis by non-invasive tests of liver fibrosis. Clin Mol Hepatol. 2015;21(3):200–211. doi:10.3350/cmh.2015.21.3.200
  • Zhu MY, Zou X, Li Q, et al. A novel noninvasive algorithm for the assessment of liver fibrosis in patients with chronic hepatitis B virus infection. J Viral Hepat. 2017;24(7):589–598. doi:10.1111/jvh.12682
  • Younossi ZM, Stepanova M, Rafiq N, et al. Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality. Hepatology. 2011;53(6):1874–1882. doi:10.1002/hep.24268
  • Yano M, Kumada H, Kage M, et al. The long-term pathological evolution of chronic hepatitis C. Hepatology. 1996;23(6):1334–1340. doi:10.1002/hep.510230607
  • Unalp-Arida A, Ruhl CE. Liver fibrosis scores predict liver disease mortality in the United States population. Hepatology. 2017;66(1):84–95. doi:10.1002/hep.29113
  • Crossan C, Tsochatzis EA, Longworth L, et al. Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis B in the UK: systematic review and economic evaluation. J Viral Hepat. 2016;23(2):139–149. doi:10.1111/jvh.12469
  • Tsochatzis EA, Crossan C, Longworth L, et al. Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C. Hepatology. 2014;60(3):832–843. doi:10.1002/hep.27296
  • Xu XY, Wang WS, Zhang QM, et al. Performance of common imaging techniques vs serum biomarkers in assessing fibrosis in patients with chronic hepatitis B: a systematic review and meta-analysis. World J Clin Cases. 2019;7(15):2022–2037. doi:10.12998/wjcc.v7.i15.2022
  • Castera L. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology. 2012;142(6):1293–1302 e1294. doi:10.1053/j.gastro.2012.02.017
  • Castera L. Hepatitis B: are non-invasive markers of liver fibrosis reliable? Liver Int. 2014;34(Suppl 1):91–96. doi:10.1111/liv.12393
  • da Silva RGJ, de Miranda MLQ, de Araujo Caldeira Brant PE, et al. Acoustic radiation force impulse elastography and liver fibrosis risk scores in severe obesity. Arch Endocrinol Metab. 2021;65(6):730–738. doi:10.20945/2359-3997000000397
  • Liu J, Li Y, Yang X, et al. Comparison of two-dimensional shear wave elastography with nine serum fibrosis indices to assess liver fibrosis in patients with chronic hepatitis B: a prospective cohort study. Ultraschall Med. 2019;40(2):237–246. doi:10.1055/a-0796-6584
  • Hu YC, Liu H, Liu XY, et al. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B. World J Gastroenterol. 2017;23(41):7425–7432. doi:10.3748/wjg.v23.i41.7425
  • Huang R, Yang CC, Liu Y, et al. Association of serum gamma-glutamyl transferase with treatment outcome in chronic hepatitis B patients. World J Gastroenterol. 2015;21(34):9957–9965. doi:10.3748/wjg.v21.i34.9957
  • Zhou K, Gao CF, Zhao YP, et al. Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis B. J Gastroenterol Hepatol. 2010;25(9):1569–1577. doi:10.1111/j.1440-1746.2010.06383.x
  • Ding R, Zheng J, Huang D, et al. INR-to-platelet ratio (INPR) as a novel noninvasive index for predicting liver fibrosis in chronic hepatitis B. Int J Med Sci. 2021;18(5):1159–1166. doi:10.7150/ijms.51799
  • Lu XJ, Yang XJ, Sun JY, Zhang X, Yuan ZX, Li XH. FibroBox: a novel noninvasive tool for predicting significant liver fibrosis and cirrhosis in HBV infected patients. Biomark Res. 2020;8:48. doi:10.1186/s40364-020-00215-2
  • Zeng DW, Liu YR, Zhang JM, et al. Serum ceruloplasmin levels correlate negatively with liver fibrosis in males with chronic hepatitis B: a new noninvasive model for predicting liver fibrosis in HBV-related liver disease. PLoS One. 2013;8(10):e77942. doi:10.1371/journal.pone.0077942
  • Eminler AT, Irak K, Ayyildiz T, et al. The relation between liver histopathology and GGT levels in viral hepatitis: more important in hepatitis B. Turk J Gastroenterol. 2014;25(4):411–415. doi:10.5152/tjg.2014.3693
  • Silva IS, Ferraz ML, Perez RM, Lanzoni VP, Figueiredo VM, Silva AE. Role of gamma-glutamyl transferase activity in patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol. 2004;19(3):314–318. doi:10.1111/j.1440-1746.2003.03256.x
  • Cheng D, Wan G, Sun L, Wang X, Ou W, Xing H. A novel diagnostic nomogram for noninvasive evaluating liver fibrosis in patients with chronic hepatitis B virus infection. Biomed Res Int. 2020;2020:5218930. doi:10.1155/2020/5218930
  • Nishikawa H, Hasegawa K, Ishii A, et al. A proposed predictive model for advanced fibrosis in patients with chronic hepatitis B and its validation. Medicine. 2016;95(35):e4679. doi:10.1097/MD.0000000000004679
  • Arena U, Vizzutti F, Corti G, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology. 2008;47(2):380–384. doi:10.1002/hep.22007
  • Song ZZ. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology. 2008;48(1):349–350; author reply 350. doi:10.1002/hep.22385